Literature DB >> 25332568

Response to corticosteroids and cytotoxic drugs in a case of idiopathic hypereosinophilic syndrome with predominantly elevated eosinophils and multiple clinical manifestations.

Zhi-Ping Guo1, Lin-Hua Yang1, Jian-Fang Chen1, Xiu-Hua Chen1, Yao-Fang Zhang1.   

Abstract

In the present case study, a 42-year-old Chinese woman fulfilling the WHO criteria for idiopathic hypereosinophilic syndrome (IHES) who exhibited clinical manifestations of eosinophilic infiltration of multiple tissues including the lungs, heart, central and peripheral nervous system, gastrointestinal tract, spleen, liver and unexplained clinical findings is described. Laboratory investigations revealed the topmost white blood cell and eosinophil that were 150 × 10(9)/L and 136 × 10(9)/L (90.6 %), respectively. To our knowledge, such a large number of eosinophils has rarely been reported, and all reactive causes of hypereosinophilia were excluded. Treatment with cytotoxic chemotherapy, prednisone and dexamethasone was not beneficial. The patient showed a remarkable hematological response when methylprednisolone pulse therapy was initiated when progression of respiratory symptoms occurred, but without clinical remission. The patient subsequently died. We consider that her critical organ damage and poor prognosis were related to the large number of eosinophils and delayed effective anti-eosinophilic therapy after severe organ damage occurred. This case highlights the clinical importance of methylprednisolone pulse therapy which should be initiated without delay once the diagnosis of IHES is made.

Entities:  

Keywords:  Chemotherapy; Clinical studies; Corticosteroids; Hypereosinophilic syndrome

Year:  2014        PMID: 25332568      PMCID: PMC4192226          DOI: 10.1007/s12288-013-0310-z

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  25 in total

1.  An infant with hypereosinophilic syndrome and heart failure markedly responded to prednisolone: serial changes of left ventricular wall thickening and left ventricular diastolic dysfunction observed by echocardiography.

Authors:  T Ito; K Harada; G Takada
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

2.  Heart failure mimicking prior myocardial infarction in a patient with idiopathic hypereosinophilic syndrome.

Authors:  Celina Wojciechowska; Anna Gala; Agnieszka Kuczaj; Wojciech Jachec; Ala Foremny; Grzegorz Helbig; Romuald Wojnicz; Ewa Nowalany-Kozielska
Journal:  Int Heart J       Date:  2011       Impact factor: 1.862

Review 3.  Eosinophilic myocarditis manifesting as myocardial infarction: early diagnosis and successful treatment.

Authors:  L Galiuto; M Enriquez-Sarano; G S Reeder; H D Tazelaar; J T Li; F A Miller; G J Gleich
Journal:  Mayo Clin Proc       Date:  1997-07       Impact factor: 7.616

4.  Clinical features of fifteen patients with the hypereosinophilic syndrome.

Authors:  C J Spry; J Davies; P C Tai; E G Olsen; C M Oakley; J F Goodwin
Journal:  Q J Med       Date:  1983

5.  2-Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndrome.

Authors:  Elias Jabbour; Srdan Verstovsek; Francis Giles; Varsha Gandhi; Jorge Cortes; Susan O'Brien; William Plunkett; Guillermo Garcia-Manero; C Ellen Jackson; Hagop Kantarjian; Michael Andreeff
Journal:  Cancer       Date:  2005-08-01       Impact factor: 6.860

Review 6.  Eosinophilic myocarditis: case series and review of literature.

Authors:  Abdullah M Al Ali; Lynn P Straatman; Michael F Allard; Andrew P Ignaszewski
Journal:  Can J Cardiol       Date:  2006-12       Impact factor: 5.223

7.  Hypereosinophilic syndrome with pulmonary and cardiac involvement in a patient with asthma.

Authors:  Demet Karnak; Oya Kayacan; Sumru Beder; Mustafa Delibalta
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

8.  Response to vincristine treatment in a case of idiopathic hypereosinophilic syndrome with multiple clinical manifestations.

Authors:  E Cofrancesco; M Cortellaro; E Pogliani; C Boschetti; M Salvatore; E E Polli
Journal:  Acta Haematol       Date:  1984       Impact factor: 2.195

Review 9.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

Review 10.  Cardiovascular manifestations of hypereosinophilic syndromes.

Authors:  Princess U Ogbogu; Douglas R Rosing; McDonald K Horne
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.